Capricor Therapeutics (CAPR) Interest Expenses (2013 - 2017)

Capricor Therapeutics' Interest Expenses history runs 5 years deep, the most recent figure standing at $80307.0 for Q4 2017.

• In Q4 2017, Interest Expenses fell 21.96% year-over-year to $80307.0; the TTM figure through Sep 2018 stood at $80307.0 (down 80.94% YoY), while the FY2025 annual figure was $3.0 million, changed N/A from the prior year.
• Interest Expenses was $80307.0 for Q4 2017 at Capricor Therapeutics, down from $107653.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $107653.0 in Q3 2017 to a low of $3711.0 in Q1 2013.
• Historically, Interest Expenses has averaged $62536.9 across 5 years, with a median of $61681.0 in 2015.
• The sharpest annual moves came in 2014 and 2017: Interest Expenses soared 780.76% in 2014, then dropped 21.96% in 2017.
• A 5-year view of Interest Expenses shows it stood at $24859.0 in 2013, then surged by 142.9% to $60383.0 in 2014, then increased by 5.3% to $63583.0 in 2015, then surged by 61.84% to $102905.0 in 2016, then retreated by 21.96% to $80307.0 in 2017.
• The last three Interest Expenses figures came in at $80307.0 (Q4 2017), $107653.0 (Q3 2017), and $105527.0 (Q2 2017), per Business Quant data.